Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Joo Young | - |
dc.contributor.author | Kim, Jisup | - |
dc.contributor.author | Kim, Yong-il | - |
dc.contributor.author | Yang, Dong-Hoon | - |
dc.contributor.author | Yoo, Changhoon | - |
dc.contributor.author | Park, In Ja | - |
dc.contributor.author | Ryoo, Baek-Yeol | - |
dc.contributor.author | Ryu, Jin-Sook | - |
dc.contributor.author | Hong, Seung-Mo | - |
dc.date.accessioned | 2024-03-21T11:00:15Z | - |
dc.date.available | 2024-03-21T11:00:15Z | - |
dc.date.issued | 2024-02 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90775 | - |
dc.description.abstract | Somatostatin analogues have recently been used as therapeutic targets for metastatic or surgically unresectable gastroenteropancreatic (GEP) neuroendocrine tumors (NETs), and associated somatostatin receptor (SSTR) expression has been well demonstrated in most GEP NETs, with the exception of rectal NETs. SSTR2 immunohistochemical expressions were evaluated in 350 surgically or endoscopically resected rectal NETs and compared to clinicopathologic factors. SSTR2 expression was observed in 234 (66.9%) rectal NET cases and associated tumors with smaller size (p = 0.001), low pT classification (p = 0.030), low AJCC tumor stage (p = 0.012), and absence of chromogranin expression (p = 0.009). Patients with rectal NET and SSTR2 expression had significantly better overall survival than those without SSTR2 expression both by univariable (p = 0.006) and multivariable (p = 0.014) analyses. In summary, approximately two-thirds of rectal NETs expressed SSTR2. SSTR2 expression was significantly associated with favorable behavior and good overall survival in patients with rectal NETs. Furthermore, SSTR2 expression can be used as prognostic factors. When metastatic disease occurs, SSTR2 expression can be used a possible target for somatostatin analogues. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | NATURE PORTFOLIO | - |
dc.title | Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors | - |
dc.type | Article | - |
dc.identifier.wosid | 001167137100060 | - |
dc.identifier.doi | 10.1038/s41598-024-54599-4 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.14, no.1 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85185324511 | - |
dc.citation.title | SCIENTIFIC REPORTS | - |
dc.citation.volume | 14 | - |
dc.citation.number | 1 | - |
dc.type.docType | Article | - |
dc.publisher.location | 독일 | - |
dc.subject.keywordAuthor | Somatostatin | - |
dc.subject.keywordAuthor | Receptor 2 | - |
dc.subject.keywordAuthor | Rectum | - |
dc.subject.keywordAuthor | Neuroendocrine tumor | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordPlus | FUNCTIONAL-CHARACTERIZATION | - |
dc.subject.keywordPlus | SUBTYPES | - |
dc.subject.keywordPlus | CLONING | - |
dc.subject.keywordPlus | FAMILY | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.